Follow this preprint
ROBI: a Robust and Optimized Biomarker Identifier to increase the likelihood of discovering relevant radiomic features
View ORCID ProfileLouis Rebaud, View ORCID ProfileNicolò Capobianco, View ORCID ProfileClémentine Sarkozy, View ORCID ProfileAnne-Ségolène Cottereau, View ORCID ProfileLaetitia Vercellino, View ORCID ProfileOlivier Casasnovas, View ORCID ProfileCatherine Thieblemont, View ORCID ProfileBruce Spottiswoode, View ORCID ProfileIrène Buvat
doi: https://doi.org/10.1101/2024.09.09.24313059
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Louis Rebaud
1Siemens Healthcare SAS
2LITO laboratory, UMR 1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France
Nicolò Capobianco
3Siemens Healthcare GmbH, Germany
Clémentine Sarkozy
2LITO laboratory, UMR 1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France
4Institut Curie, Saint Cloud, Paris, France
Anne-Ségolène Cottereau
2LITO laboratory, UMR 1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France
5Department of Nuclear Medicine, Cochin Hospital, AP-HP, Université Paris Cité, Paris, France
Laetitia Vercellino
6Department of Nuclear Medicine, Saint-Louis Hospital, AP-HP, Paris, France
7Inserm, UMR_S942 MASCOT, Université Paris Cité, F-75006, Paris, France
Olivier Casasnovas
8Department of Hematology, University Hospital of Dijon, INSERM 1231, Dijon, France
Catherine Thieblemont
9Université Paris Cité, 85 boulevard St Germain, F-75006 Paris, France
10Assistance Publique – Hôpitaux de Paris, Saint Louis Hospital, Hemato-oncology, Paris, France
11Inserm U1153, Hôpital Saint Louis, 1 avenue Claude Vellefaux, F-75010 Paris, France
Bruce Spottiswoode
12Siemens Medical Solutions USA, Inc., Knoxville, Tennessee, United States
Irène Buvat
2LITO laboratory, UMR 1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France

Posted September 10, 2024.
ROBI: a Robust and Optimized Biomarker Identifier to increase the likelihood of discovering relevant radiomic features
Louis Rebaud, Nicolò Capobianco, Clémentine Sarkozy, Anne-Ségolène Cottereau, Laetitia Vercellino, Olivier Casasnovas, Catherine Thieblemont, Bruce Spottiswoode, Irène Buvat
medRxiv 2024.09.09.24313059; doi: https://doi.org/10.1101/2024.09.09.24313059
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (417)
- Allergy and Immunology (739)
- Anesthesia (216)
- Cardiovascular Medicine (3160)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13128)
- Forensic Medicine (15)
- Gastroenterology (876)
- Genetic and Genomic Medicine (4954)
- Geriatric Medicine (456)
- Health Economics (760)
- Health Informatics (3114)
- Health Policy (1112)
- Hematology (417)
- HIV/AIDS (984)
- Medical Education (460)
- Medical Ethics (121)
- Nephrology (509)
- Neurology (4704)
- Nursing (249)
- Nutrition (697)
- Oncology (2430)
- Ophthalmology (690)
- Orthopedics (272)
- Otolaryngology (335)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1260)
- Primary Care Research (530)
- Public and Global Health (7274)
- Radiology and Imaging (1625)
- Respiratory Medicine (951)
- Rheumatology (464)
- Sports Medicine (409)
- Surgery (526)
- Toxicology (66)
- Transplantation (223)
- Urology (193)